Considering that Pirfenidone is metabolised through the CYP1A2 enzyme pathway, any drug which inhibits this enzyme is likely to precipitate the toxicity of pirfenidone: concomitant therapy is to be avoided. Stay clear of; coadministration of pirfenidone and reasonable CYP1A2 inhibitors result in moderately elevated publicity to pirfenidone; if unable to https://1-2-3-6-tetragalloylgluco00886.blogdomago.com/29008321/little-known-facts-about-glecaprevir